| P value | Exp(B) | 95.0% CI for Exp(B) | |
---|---|---|---|---|
Lower | Upper | |||
Age | .195 | 1.038 | .981 | 1.099 |
Sex | .400 | 1.963 | .408 | 9.448 |
T Stage | ||||
 T1 (reference) | .155 |  |  |  |
 T2 | .522 | 1.883 | .271 | 13.065 |
 T3 | .115 | .247 | .044 | 1.405 |
 T4 | .850 | 1.215 | .161 | 9.185 |
N Stage | ||||
 N0 (reference) | .445 |  |  |  |
 N1 | .170 | .162 | .012 | 2.177 |
 N2 | .223 | .228 | .021 | 2.456 |
 N3 | .837 | .821 | .125 | 5.386 |
Induction ChTa | .463 | .625 | .178 | 2.191 |
Receiving Planned RT dose (70Gy) | .093 | 3.675 | .805 | 16.772 |
Receiving Planned ChT Cyclesb | .025 | 6.351 | 1.268 | 31.815 |
Duration of RT | .831 | 1.007 | .948 | 1.069 |
Locoregional recurrence | .025 | .157 | .031 | .796 |
Distant metastasis | .000 | .014 | .002 | .107 |